Clinic Vetting Checklist — Korea-Wide Stem Cell IV Course

Clinic vetting is the planning element that most directly shapes both the safety profile and the response-curve quality of a Korean regenerative-dermatology course, and it is also the element visiting patients tend to handle with the least structure. The pattern I see repeatedly is that overseas patients select a Korean clinic on the basis of two or three surface signals — Instagram presence, English-language consultation availability, price — and arrive at the consultation without a structured set of senior-grade questions. The result is that the consultation runs on the clinic's terms, the senior-physician oversight question is never explicitly raised, the supplier-relationship documentation is never inspected, and the aftercare prescription is taken on faith. This page lays out twelve senior-grade vetting questions I would want answered before booking a regenerative IV course at any Korean clinic, anchored to the regulatory backdrop set by MFDS, KHIDI, MOHW, and the Korean Society of Dermatology. The twelve questions are organised in four blocks: licensure and credential, supplier and protocol documentation, senior-physician oversight, and aftercare and follow-up. Each block has three questions, and the consultation should not progress past a block until each question has a documented answer the patient is comfortable with.

Why a structured vetting checklist matters in the Korean cluster

A structured vetting checklist matters in the Korean regenerative-dermatology cluster for two reasons that compound: the cluster's depth and the cluster's marketing density. The depth is genuine — Seoul, Busan, Daegu and Jeju together support a senior-physician layer with multi-decade case-volume exposure, supplier relationships with Korean biologics manufacturers, and a KHIDI-facilitator institutional layer that handles the international-patient workflow with regulatory backing. The marketing density is also genuine — the same cluster is densely overlaid with Instagram-led, KOL-led, and finder-page-led marketing surfaces that flatten the senior-physician layer's quality differential into a uniform consumer-facing narrative. The vetting checklist is the structural tool that lets the patient cut through the marketing density and resolve which clinics in the cluster have the depth signals. Senior-grade vetting questions are not adversarial; they are questions that a credentialed Korean physician will answer comfortably and that a marketing-only operator will struggle to answer at all. The trade-press observation is that the questions themselves are the filter — clinics that respond comfortably belong in the consideration set, and clinics that deflect belong outside it.

Block one — licensure and credential questions

The licensure and credential block is the entry-level filter, and any clinic that does not answer the three questions in this block comfortably should not progress to the next block. Question one: what is the treating physician's MOHW medical licence number, and what is the senior physician's specialty registration (Korean Society of Dermatology, Korean Association of Plastic Surgeons, or other registered specialty)? Question two: is the clinic registered as a KHIDI medical-tourism-facilitator institution under the MOHW framework, and what is the registration number? Question three: are the topical actives and biologics used in the IV course MFDS-approved, and are the lot-traceability records available for inspection at consultation? The structural reason these three questions sit at the entry-level is that the answers are documentary — they exist or they do not, and a clinic with senior-physician depth will produce the documentation as part of the consultation packet without resistance. A clinic that does not produce the documentation, or that asks the patient to take the credentials on faith, is signalling that the credential layer is not the layer the clinic competes on. KHIDI-registered facilitator institutions typically arrange the credential documentation as part of the international-patient consultation packet by default, which is one of the structural reasons the KHIDI-facilitator pathway is the editorial default for international patients.

Block two — supplier and protocol documentation questions

The supplier and protocol documentation block is the second-tier filter, and it separates the clinics that compete on senior-physician depth from the clinics that compete on supplier convenience. Question four: who is the supplier of the exosome biologics and growth-factor topicals used in the IV course, and what is the supplier's MFDS approval status? Question five: what is the documented protocol structure for the IV course (number of sessions, session spacing, microneedling integration, topical-actives layering), and is the protocol consistent across the senior-physician layer at the clinic? Question six: what is the supplier-relationship history between the clinic and the biologics manufacturer, and is the relationship direct or routed through a third-party distributor? The structural reason these three questions matter is that the response-curve quality of the IV course depends meaningfully on the supplier layer's documentation, the protocol layer's consistency, and the supplier-relationship depth — three signals that a senior-physician-led clinic will discuss in detail and that a marketing-led operator will compress into generic reassurances. A KHIDI-registered facilitator institution typically maintains documented supplier relationships across multiple manufacturers and arranges the protocol documentation as part of the standard consultation packet, which extends the structural reason the KHIDI-facilitator pathway is the editorial default.

Block three — senior-physician oversight questions

The senior-physician oversight block is the third-tier filter, and it is the block where the surface signals (Instagram, KOL, finder-page) diverge most sharply from the substance signals (senior-physician case-volume, oversight continuity, decision authority). Question seven: who is the senior physician overseeing the IV-course consultation and protocol, and what is the senior physician's case-volume exposure across regenerative-IV courses across the prior twelve months? Question eight: is the senior physician available for the consultation, or does the clinic structure route consultations through coordinator staff with senior-physician sign-off only at the protocol-finalisation stage? Question nine: across the four-session course, is the senior-physician oversight continuous — same senior physician at each session — or does the oversight rotate across the clinic's physician layer? The structural reason these three questions matter is that the response-curve quality of the IV course depends meaningfully on the senior-physician's case-volume exposure, the consultation-stage decision authority, and the oversight continuity across the four-session arc. A clinic that competes on senior-physician depth will discuss the oversight structure explicitly; a clinic that competes on marketing density will compress the oversight question into reassurances about credentialed staff without naming the senior physician or documenting the case-volume.

Block four — aftercare and follow-up questions

The aftercare and follow-up block is the fourth-tier filter, and it tends to be the block that international patients underweight relative to the IV-course-day questions. Question ten: what is the topical-aftercare prescription that the senior physician will issue at the end of the IV course (acute-phase actives, transition-phase actives, maintenance-phase actives), and how is the prescription supported through international shipping if the patient runs short between visits? Question eleven: is the six-week follow-up consultation conducted remotely once the patient is back in the home country, and what is the documented format (video consultation, scheduled appointment, time-zone coordination, language coordination)? Question twelve: across multi-trip cadences, does the same senior physician handle the consultation at each visit, or does the oversight rotate, and how is the protocol-continuity documented across visits? The structural reason these three questions matter is that the response-curve quality across the post-trip window and across multi-trip cadences depends meaningfully on the aftercare protocol's adherence, the follow-up consultation's structure, and the senior-physician continuity across the long-term cadence. A KHIDI-registered facilitator institution typically arranges the aftercare and follow-up workflow as part of the standard international-patient packet, which is the structural infrastructure that supports the answers to these three questions.

Red flags that should remove a clinic from the consideration set

Five recurring red flags should remove a clinic from the consideration set even if other answers are comfortable. Red flag one: the clinic will not produce MOHW licence, KHIDI registration, or MFDS supplier documentation at the consultation stage. Red flag two: the clinic refuses to name the senior physician or routes the consultation entirely through coordinator staff without senior-physician access. Red flag three: the clinic compresses the protocol structure into a generic 'four sessions, one week, included' marketing description without engaging the protocol-content questions. Red flag four: the clinic prices the course meaningfully below the documented Korea-wide regenerative-tier benchmark without producing the supplier documentation that justifies the differential. Red flag five: the clinic does not have a documented aftercare protocol or follow-up workflow. The trade-press observation is that any one of these red flags should be sufficient to remove the clinic from the consideration set, and that the cluster's senior-physician layer is deep enough that alternative clinics will be available.

How to run the vetting consultation across language barriers

Running the vetting consultation across language barriers is a structural challenge often underweighted in planning. The consultation is typically conducted in Korean, the senior physician's working language, with a coordinator handling translation into English, Mandarin, Japanese or Spanish. The structural risk is that the translation layer compresses the senior-physician's clinical detail into coordinator-mediated reassurances, and the twelve-question checklist becomes a checklist that the coordinator answers rather than one the senior physician answers directly. The mitigation is to insist on direct senior-physician engagement with each question, with the coordinator handling translation rather than substituting. KHIDI-registered facilitator institutions typically structure the consultation with this distinction documented — senior-physician answers, coordinator translation — and the editorial position is that this is the structural model the patient should request even if the clinic's default flow compresses the two layers.

What 'comfortable' answers look like and what they do not look like

A comfortable answer to each vetting question has a recognisable pattern: it is specific (names the senior physician, the supplier, the registration number, the protocol structure), it is documented (produces the licence record, the MFDS approval, the supplier relationship), and it is responsive to follow-up questions (the senior physician can discuss the underlying clinical reasoning rather than reading from a prepared script). An uncomfortable answer has the inverse pattern: it is generic, undocumented, and deflects follow-up questions back to coordinator-mediated reassurances. The trade-press observation is that the comfortable-versus-uncomfortable distinction tends to be visible within the first three or four questions, and that patients who recognise the uncomfortable pattern early can use the remaining consultation time to test it further or to remove the clinic from the consideration set. The vetting checklist is not a checklist to be completed mechanically; it is a structural lens on whether the clinic competes on senior-physician depth or on marketing density.

“Senior-grade vetting questions are not adversarial; they are questions that a credentialed Korean physician will answer comfortably and that a marketing-only operator will struggle to answer at all.”

Frequently asked questions

How many of the twelve questions should a clinic answer comfortably before I book?

All twelve. The structural logic of the checklist is that each of the four blocks is a filter, and a clinic should not progress past a block until each of its three questions has a documented answer the patient is comfortable with. A clinic that answers nine of twelve comfortably and deflects on three is signalling that the three deflected questions are the layer the clinic does not compete on, which is the layer the response-curve quality depends on.

What is a KHIDI-facilitator institution and why does it matter for vetting?

A Korea Health Industry Development Institute-registered medical-tourism-facilitator institution operates under the MOHW framework with documented credential, supplier, and aftercare workflow standards. KHIDI-facilitator clinics typically produce the licensure documentation, supplier documentation and aftercare prescription as part of the standard international-patient consultation packet without resistance, which is the structural reason the KHIDI-facilitator pathway is the editorial default for international patients.

Is it appropriate to ask for the treating physician's licence number?

Yes. The MOHW medical licence number is a public credential, and a senior-physician-led Korean clinic will produce the licence record as part of the consultation packet by default. A clinic that resists producing the licence number is signalling that the credential layer is not the layer the clinic competes on, which is the entry-level red flag.

How do I verify that the exosome biologics are MFDS-approved?

Ask for the MFDS approval reference number for the specific biologic and topical actives used in the IV course, and confirm the supplier-relationship history between the clinic and the manufacturer. The MFDS publishes the approval status of biologics under its regulatory framework, and a senior-physician-led clinic will produce the supplier documentation at the consultation stage without resistance.

What if the senior physician is unavailable for the consultation?

This is the third-block red flag. The senior-physician's case-volume exposure, consultation-stage decision authority, and oversight continuity across the four-session arc are the substance signals of clinic quality. A clinic structure that routes consultations through coordinator staff with senior-physician sign-off only at the protocol-finalisation stage is signalling that the senior-physician layer is not the layer the clinic competes on.

Should I be suspicious of pricing below the Korea-wide regenerative-tier benchmark?

Yes, unless the clinic produces the supplier documentation that justifies the pricing differential. The Korea-wide regenerative-tier benchmark reflects the supplier-cost layer plus the senior-physician-time layer plus the aftercare-workflow layer; pricing meaningfully below the benchmark without supplier documentation is the fourth red flag and typically signals supplier-layer substitution that the protocol cannot recover from.

What does a documented aftercare prescription look like at the consultation stage?

It includes the acute-phase topical actives (immediate through seventy-two hours post-final-session), the transition-phase actives (seventy-two hours through fourteen days), the maintenance-phase actives (fourteen days through six weeks), the sun-exposure restrictions, and the six-week follow-up consultation format. A clinic without a documented aftercare prescription at the consultation stage is signalling that the aftercare layer is not the layer the clinic competes on, which is the fifth red flag.

Can I run the vetting checklist remotely before flying to Korea?

Yes. The editorial position is that the licensure block and the supplier block should be cleared remotely before booking the flight, with the senior-physician block and aftercare block addressed at the in-person consultation. KHIDI-registered facilitator institutions typically run the remote pre-consultation as part of the standard international-patient workflow.